In colorectal cancer (CRC), PSG9 has been shown to promote angiogenesis through interaction with SMAD4, leading to enhanced nuclear retention of SMAD4 and activation of angiogenesis-related genes such as VEGFA and PDGF-AA [24]. The gene discussed is VEGFA; the disease is colorectal carcinoma.